Life Sciences Inc Manufacturer

Listing Websites About Life Sciences Inc

Filter Type:


Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave

(Right now) ("Third Wave'') to help drive brand awareness of the company's Psychedelics Genetic Test kit, developed and commercialized by wholly-owned subsidiary HaluGen Life Sciences Inc. ("HaluGen"). The agreement with Third Wave - an organization committed to sharing trusted, research-based content and resources for safe, structured, and responsible psychedelic use - represents an opportunity to expand access to and visibility for HaluGen's Psychedelics Genetic Test Kit, which was launched in the US on June 6, ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Tennessee Mesothelioma Treatment and Doctors - Mesothelioma.net

(Right now) This page has been fact checked by an experienced mesothelioma Patient Advocate. Sources of information are listed at the bottom of the article. We make every attempt to keep our information accurate and up-to-date. Tennessee mesothelioma treatment and doctors play a pivotal role in helping patients with this terrible diagnosis live longer and better.

Url:  Visit Now 

Category:  Health Detail Drugs 


Solidarity Fridays - Week 24 – Psychedelics Today

(1 day(s) ago) Robin Carhart-Harris, who joined in November), European psychedelic-assisted psychotherapy company AWAKN Life Sciences Inc. announcing the launch of its Commercial Clinical Research Division with Professor David Nutt and (past Psychedelics Today guest) Dr. Ben Sessa at the helm, a recent study at the National Center for Biotechnology Information that further proved that psychedelics promote structural and functional neural plasticity, and a new app called “Trip” from Field Trip Psychedelics Inc., which ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Identification of new drug candidates against Borrelia burgdorferi usi | DDDT

(1 day(s) ago) A total of 50 μL of BSK-II medium was added to white 384-well Corning plates (Corning Incorporated) using the Matrix Wellmate, and ~100 nL of each compound from the stock solution was added using the pin tool in the Staccato System (CaliperLS, Caliper Life Sciences Inc, Alameda, CA) to 1–22 columns. The last two columns of the 384 wells were left for culturing the controls. We screened one compound per well in a 384-well microplate format. These are screened in a 7-point titration ranging from 25 μM, ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Bioniche Life Sciences Inc. Rebrands As Telesta Therapeutics Inc. | BioSpace

(3 day(s) ago) Bioniche Life Sciences Inc. Rebrands As Telesta Therapeutics Inc. • • November 24, 2014 By Krystle Vermes, BioSpace.com Breaking News Staff • Canadian life sciences firm Bioniche Life Sciences Inc. announced today that it will be changing its name to Telesta Therapeutics Inc. This comes after the business revealed its shift toward late stage human therapeutics with near-term commercial potential. • As a result of this name change, the company will go from TSX:TST on the Toronto Stock Exchange to TSC:BNC. ...

Url:  Visit Now 

Category:  Health Detail Drugs 


DNA Archives – Huntington's Disease News

(3 day(s) ago) Courtagen Life Sciences, Inc., released several new Next Generation Sequencing tests designed to evaluate people with epilepsy and mitochondrial disease. Mitochondrial diseases are inherited or chronic illness. They can occur either at birth or may develop later, and include problems with development and cognition. They may cause poor growth, lack of coordination, weakness, pain and seizures.

Url:  Visit Now 

Category:  Health Detail Drugs 


Recognify Life Sciences to Commence Phase 2a Study in Cognitive Impairment Associated with Schizophrenia - atai Life Sciences

(3 day(s) ago) Recognify Life Sciences, Inc., an atai Life Sciences platform company focused on developing treatments for cognitive impairment with initial efforts targeting Cognitive Impairment Associated with Schizophrenia (CIAS), today announced it has initiated a Phase 2a study for its lead compound RL-007, after receiving IND clearance from the Food and Drug Administration to commence clinical trials in the United States in this indication.

Url:  Visit Now 

Category:  Health Detail Drugs 


Novel Small Molecule Technology Reverses Life-Threatening Opioid-Induced Respiratory Depression - CvilleBioHub

(5 day(s) ago) Case Western Reserve University and Atelerix Life Sciences Inc., a Charlottesville, Virginia-based biotechnology company, have signed a two-year option to license a novel family of small molecules called Active Thiol-Based Compounds (ATBC’s) to prevent or reverse life-threatening opioid-related side effects. The lead compound, ATLX–0199 (also called sudaxine), will be first targeted at opioid-induced respiratory depression (OIRD) in the hospital setting. A recent study by the medical technology company ...

Url:  Visit Now 

Category:  Health Detail Drugs 


2021-04-06 | CSE:ENBI | Press Release | Entheon Biomedical Corp Com

(7 day(s) ago) (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces the launch of the industry's first Psychedelics Genetic Test Kit, developed by wholly-owned subsidiary, HaluGen Life Sciences Inc. ("HaluGen"), and that it is now available for sale within Canada. HaluGen's psychedelic pre-screening platform and DNA testing provides genetic, personal and familial insights to better inform one's psychedelic assisted ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Creso Pharma target Halucenex Life Sciences Inc progresses psychedelic US market entry strategy

(8 day(s) ago) Creso Pharma Ltd’s (ASX:CPH) (FRA:1X8) target acquisition company Halucenex Life Sciences Inc has entered into a consultancy agreement with US-based scientific consultancy HeteroGeneity LLC to progress a US market entry strategy for the potential use and licensing of botanical psilocybin products and compounds. HeteroGeneity provides strategic and technical assistance to clients conducting R&D and commercialisation of drugs, biologics and medical devices for the US and Canadian markets. Under the ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Achieve Life Science Announces Advancement of Cytisine Clinical Development Program

(8 day(s) ago) Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, recently announced the commencement of a multi-dose study to evaluate both PK and PD characteristics of cytisine. In preparation to initiate a pivotal Phase 3 trial in the United States , Achieve recently began enrollment in a multi-dose, PK/PD clinical study. An assessment of PK parameters and PD effects is planned to be conducted on both the ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Bioniche Life Sciences Inc. Rebrands as Telesta Therapeutics Inc.

(9 day(s) ago) BELLEVILLE, ON , Nov. 24, 2014 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC PNK: BNHLF) Bioniche Life Sciences today announced the accomplishment of another major milestone in the execution of its strategic plan to become a focused late stage human therapeutics company with near term commercial potential. Effective immediately, the Company will begin operating under its new corporate name and identity, Telesta Therapeutics Inc. Along with this name change, the Toronto Stock Exchange (TSX) will be ...

Url:  Visit Now 

Category:  Health Detail Drugs 


ReAlta Life Sciences, Inc. Doses First Patient in Phase 1b Inhaled-LPS Challenge Clinical Trial to Support Development of RLS-0071 in Severe Asthma - Life Sciences Times

(9 day(s) ago) NORFOLK, Va.– ReAlta Life Sciences, Inc. (“ReAlta”) a clinical stage, rare disease company addressing life-threatening diseases through harnessing the power of the immune system, today announced the dosing of the first patient in its Phase 1b Inhaled- lipopolysaccharide (LPS) challenge clinical trial in healthy volunteers to support development of RLS-0071 in severe asthma. RLS-0071 is the Company’s lead dual-action complement inhibitor and innate anti-inflammatory peptide in development as a treatment ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Biomol GmbH - Life Science Shop

(9 day(s) ago) Biomol and Razor TEV Protease are trademarks of Biomol GmbH. AbVantage is a trademark of of Bethyl Laboratories, Inc. Amplite is a trademark of AAT Bioquest, Inc. Anti-FLAG is a trademark of Sigma-Aldrich Co.

Url:  Visit Now 

Category:  Health Detail Drugs 


PH signs deal for 30M doses of Covovax — Serum Institute of India

(10 day(s) ago) Vaccine czar Carlito Galvez Jr. represented the country in the signing on Saturday, which the SII and its Philippine partner Faberco Life Sciences Inc. also took part in. "The vaccine is stable at 2°C to 8°C, the standard temperature that is within the existing cold chain system in the Philippines, thus allowing its distribution to the remotest barangays," said Dr. Luningning Villa, medical director of Faberco Life Sciences, adding it will be used to inoculate 15 million and vulnerable Filipinos. The ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Pineapple Express Enters Agreement to Offer Same-Day Medical...

(10 day(s) ago) (formerly WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a state-of-the-art hybrid greenhouse and processing facility located on 158-acres in Strathroy, ON; a fully licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction; and a micropropagation, tissue culture and genetics centre-of-excellence in Guelph, Ontario. With its Starseed ...

Url:  Visit Now 

Category:  Health Detail Drugs 


CM Life Sciences I - CM Life Sciences IPO Pricing Announcement

(12 day(s) ago) CM Life Sciences, Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $385 Million Initial Public Offering New York, NY – September 1, 2020 – CM Life Sciences, Inc. (the “Company”) announced today that it priced its initial public offering of 38,500,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “CMLFU” beginning September 2, 2020. Each unit consists of one share of Class A ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Marc Rivière, MD - TVM Capital Life Science Venture Capital

(12 day(s) ago) He also served as Senior Vice President, Clinical Development at Caprion Pharmaceuticals, Chief Medical Officer for Bioniche Life Sciences Inc., Managing Director of Xenon Genetics Inc., Vice President of Clinical Affairs, Aeterna Labs and Executive Vice President and Regional Director, Quintiles Inc. He was also member of the Guideline Review Committee of the Canadian Co-ordination Office of Health Technology Assessment. Marc received his Tropical Disease Medicine Certification from Université Bordeaux ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Bioniche Life Sciences Inc.

(13 day(s) ago) Bioniche has evolved into a research-based, technology-driven Canadian biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide. Key areas of strategic focus for Bioniche include developing effective therapies for bladder cancer and potentially other cancers; a cattle vaccine to help prevent E. coli O157:H7 infection; and technologies to improve reproduction and potentially replace the use of antibiotics in livestock.

Url:  Visit Now 

Category:  Health Detail Drugs 


Affinity Life Sciences, Inc. - MassBio

(13 day(s) ago) Overview Affinity Life Sciences is a contract manufacturing organization committed to providing scientific and quality expertise to meet the production demands of our customers. Our unique services offer our customers a single source for identifying and supplying raw materials, product and process development, manufacturing capabilities, and quality services. Affintiy provides a host of services including lyophilization services. Affinity Life Sciences is a cGMP and ISO 13485 compliant company can ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Investor Relations | Comera Life Sciences

(13 day(s) ago) Comera Life Sciences, Inc. is a life sciences company dedicated to promoting a compassionate new era in medicine. We apply a deep knowledge of formulation science and proprietary technology to optimize biologic medicines. Our internal portfolio of proprietary techniques known as our SQore™ platform, is designed to potentially transform essential biologic medicines from intravenous to subcutaneous forms; optimize current versions of subcutaneous biologics; and produce biosimilar versions of existing ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Affinity Life Sciences Employment | Affinity Life Sciences Jobs

(14 day(s) ago) EMPLOYMENT OPPORTUNIES AT AFFINITY LIFE SCIENCES, AMHERST, NH Currently there are no vacancies available at this time. • Affinity Life Sciences, Inc. is an equal opportunity employer providing competitive compensation and benefits, including vacation, Retirement plan, and Health benefits.

Url:  Visit Now 

Category:  Health Detail Drugs 


Awakn Life Sciences Lists on the NEO Exchange - PSYCH

(14 day(s) ago) The listing follows the successful completion of the previously announced reverse takeover of a Canadian public company, 2835517 Ontario Ltd., by Toronto-based Awakn Life Sciences Inc. The public company was subsequently renamed Awakn Life Sciences Corp. in connection with the reverse takeover and the listing on the NEO. Additionally, the Company raised gross proceeds of approximately US$8.3 million through a brokered private placement. Awakn engaged Canaccord Genuity Corp. and Eight Capital as co-lead ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells

(14 day(s) ago) Introduction The serine/threonine protein kinase AKT (also known as protein kinase B) mediates the cell survival signals coming through the phosphoinositide 3-kinase (PI3K) pathway by phosphorylation (1,2). Human AKT has three isoforms: AKT1, AKT2 and AKT3. Once activated, AKT moves to the cytoplasm and nucleus, where it phosphorylates, activates or inhibits numerous downstream targets to regulate various cellular functions, including cell proliferation. Increased expression and activation of AKT is ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Awakn announces next significant step towards public listing on the NEO

(14 day(s) ago) ("Subco"), a wholly-owned subsidiary of the Company, and Awakn Life Sciences Inc. ("Awakn"), which, subject to certain conditions and applicable shareholder and regulatory approvals, will result in a reverse takeover of the Company by Awakn (the "Proposed Transaction"). The resulting issuer from the Proposed Transaction (the "Resulting Issuer") will carry on the business of Awakn. Pursuant to the terms of the Amalgamation Agreement, the Proposed Transaction will be completed by way of a three-cornered ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Growing Potential

(14 day(s) ago) AIBMR Life Sciences Inc. (www.aibmr.com) offers full-service natural products and nutraceutical consulting services.

Url:  Visit Now 

Category:  Health Detail Drugs 


Company Information

(15 day(s) ago) Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories.

Url:  Visit Now 

Category:  Health Detail Drugs 


Wellnx Strikes Deal In Diet Products Marketing Fraud MDL - Law360

(15 day(s) ago) By Martin Bricketto (August 3, 2011, 7:57 PM EDT) -- Dietary supplement developer Wellnx Life Sciences Inc. and other defendants in multidistrict litigation over alleged false labeling and advertising reached a settlement with consumers Wednesday in Massachusetts, agreeing to refund purchasers of the weight loss products at issue. • Seeking conditional approval of a settlement that would resolve all cases in the MDL, consumers said that Wellnx and certain manufacturers of its products would pay a $14 per ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Cethromycin; Uses, Dosage, Side Effects, Drug Interactions - Rxharun

(15 day(s) ago) Originally discovered and developed by Abbott, it was acquired by Advanced Life Sciences Inc. for further development. In June 2009,an FDA Anti-Infective Drugs Advisory Committee review found insufficient evidence for cethromycin efficacy in treatment of community acquired pneumonia, as the Phase 3 clinical trial followed standards that were updated after the clinical trial but three months prior to review. The committee did, however, find the drug safe to use. Cethromycin is a ketolide antibiotic ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Cutanea Unveils Aktipak Gel, 3%/5%, Convenient Acne Treatment for "On-the-Go" Patients - Practical Dermatology

(15 day(s) ago) Cutanea Life Sciences, Inc. (CLS) introduced Aktipak(erythromycin and benzoyl peroxide) Gel, 3%/5%, a combination therapy indicated for the topical treatment of acne vulgaris. The product is available through dermatologists' offices. Aktipak is a portable, freshly mixed, patient-blended therapy that offers a flexible and convenient treatment option for active, "on-the-go" acne patients, according to the company.

Url:  Visit Now 

Category:  Health Detail Drugs 


Conditions d’utilisation - Deflux

(16 day(s) ago) Palette Life Sciences, Inc. (« Palette », « nous » ou « notre ») a créé un site Web à l’adresse www.deflux.com (le « Site Web » ou « Site ») pour fournir des informations sur le produit Deflux et aider les personnes à la recherche d’un urologue pédiatrique. Pour vous aider à utiliser le Site Web, nous avons créé (i) les présentes Conditions d’utilisation (les « Conditions ») et (ii) une Politique de confidentialité. Notre Politique de confidentialité explique comment nous traitons les informations que ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Cethromycin - Wikipedia

(16 day(s) ago) Originally discovered and developed by Abbott, it was acquired by Advanced Life Sciences Inc. for further development. On October 1, 2008 Advanced Life Sciences submitted a New Drug Application (NDA) to Food and Drug Administration (FDA) for cethromycin to treat mild-to-moderate community acquired pneumonia. On December 3, 2008 Advanced Life Sciences announced that this New Drug Application has been accepted for filing by the FDA. In June 2009, an FDA Anti-Infective Drugs Advisory Committee review found ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Aktipak - FDA prescribing information, side effects and uses

(16 day(s) ago) Generic name: erythromycin and benzoyl peroxide • Dosage form: gel • Drug class: Topical acne agents Medically reviewed by Drugs.com. Last updated on May 24, 2021. On This Page Description Clinical Pharmacology Clinical Studies Indications and Usage Contraindications Precautions Patient Counseling Information Adverse Reactions/Side Effects Dosage and Administration How Supplied/Storage and Handling Aktipak ® contains erythromycin ...

Url:  Visit Now 

Category:  Health Detail Drugs 


Aktipak (erythromycin and benzoyl peroxide) Gel 3%/5%, 60 Pouches, Cutanea Life Sciences, Inc. (RX) Ingredients and Reviews

(16 day(s) ago) Ingredients (8) Legal Disclaimer - Actual product packaging and materials may contain more and different product and ingredient information than what is shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

Url:  Visit Now 

Category:  Health Detail Drugs 


Emmaus Medical, Inc. Selects AmerisourceBergen to Support the Launch of Endari (L-glutamine oral powder)

(16 day(s) ago) Frisco, Texas – AmerisourceBergen, a global healthcare solutions leader, today announced that US Bioservices, an independent specialty pharmacy, has been selected by Emmaus Medical, Inc. as the specialty pharmacy for Endari(L-glutamine oral powder), for the treatment of patients with sickle cell disease. • The U.S. Food and Drug Administration approved Endari on July 7, 2017 for adult and pediatric patients 5 years of age and older to reduce the acute complications of sickle cell disease. Endari is the ...

Url:  Visit Now 

Category:  Health Detail Drugs 


The Belgravia Centre

(16 day(s) ago) The American Hair Research Society (AHRS) is currently holding its annual American Hair Research Summit which is on until 16th May 2018 in Orlando, Florida. One of the key talks being given is by Paul Changelian, Ph.D., the Vice President of Biology at Aclaris Therapeutics, Inc. – a company at the forefront of current hair loss developments. Through the company’s work with scientists from Columbia University in New York, and its acquiring a portfolio of exclusive patent licenses, it is one of the major ...

Url:  Visit Now 

Category:  Health Detail Drugs 

FAQ about Life Sciences Inc

What are life sciences products?

“Life sciences encompasses hard scientific development with physical products, including pharmaceuticals, therapeutics, diagnostics, medical devices, and other products that are designed to treat or aid in the treatment of patients,” Gallagher said.

Is verily life sciences part of Google?

Verily Life Sciences is described as a sister company to Google. It started life in 2015 as Google Life Sciences, part of Google X, Alphabet's research and development division, before being renamed later that year.

What is a life science company?

The life sciences industry comprises companies operating in the research, development and manufacturing of pharmaceuticals, biotechnology-based food and medicines, medical devices, biomedical technologies, nutraceuticals, cosmeceuticals, food processing, and other products that improve the lives of organisms.